Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891156812> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2891156812 abstract "7065 Background: Langerhans cell histiocytosis (LCH) is a rare disorder of histiocytic proliferation most commonly observed in children. LCH in adults is less characterized and a standard of care has not been established. Here we review clinical outcomes of adult LCH patients (pts) treated with various therapies at a large referral center. Methods: We identified 108 pts over 18 years of age with histologically confirmed LCH presenting to our center between 1990-2015. Clinical and treatment characteristics were examined and classified by single or multi-system involvement (SSI or MSI, respectively) and risk-organ involvement (ROI; liver, spleen, hematopoietic system and CNS). Overall survival (OS) and freedom from first progression (FFFP) were calculated by the Kaplan-Meier method. Univariate analysis was performed with the Cox proportional hazards model. Results: Median age at diagnosis was 44 years (range 18-89) with a median follow-up of 3.9 years (0.1-9.1). Median OS was 16.1 years and FFFP was 5.6 years, with 94 (87%) pts alive at last follow-up. Eighty-three (77%) had SSI and 13 (12%) had ROI. The most common sites of disease were bone (52 pts; 48%), lung (28; 26%), and skin (24; 22%). Only 11 pts (9%) experienced progression of disease (POD) after first treatment. Twenty-four (22%) received radiotherapy, 42 (39%) underwent excision, and 26 (24%) received systemic therapy at any point during treatment. The most common systemic agents were vinblastine, 6-mercaptopurine (6-MP), methotrexate (MTX), and cladribine. Eight received combination vinblastine, 6-MP, and MTX (VMM), 4 of which had MSI. Median progression-free survival (PFS) of VMM pts was 6 months, compared with 2.8 for all other systemic agents (p = 0.1). For OS, lack of ROI was the only significant variable upon univariate analysis (HR .22, 95%CI 0.06-0.75, p = 0.016). No variables were significant for PFS. Conclusions: Effective therapy for adult LCH has not been clearly identified. In our cohort of both low and high risk patients, the low POD rate observed is encouraging. VMM, a regimen previously studied in pediatric pts, is also effective in adults and may be considered the combination of choice for treatment of adult LCH. Further prospective study is warranted." @default.
- W2891156812 created "2018-09-27" @default.
- W2891156812 creator A5000509600 @default.
- W2891156812 creator A5007588773 @default.
- W2891156812 creator A5010046486 @default.
- W2891156812 creator A5048304251 @default.
- W2891156812 creator A5049426344 @default.
- W2891156812 creator A5058900172 @default.
- W2891156812 creator A5064937199 @default.
- W2891156812 date "2017-05-20" @default.
- W2891156812 modified "2023-09-25" @default.
- W2891156812 title "Identification of effective therapy in Langerhans cell histiocytosis in the adult population." @default.
- W2891156812 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.7065" @default.
- W2891156812 hasPublicationYear "2017" @default.
- W2891156812 type Work @default.
- W2891156812 sameAs 2891156812 @default.
- W2891156812 citedByCount "0" @default.
- W2891156812 crossrefType "journal-article" @default.
- W2891156812 hasAuthorship W2891156812A5000509600 @default.
- W2891156812 hasAuthorship W2891156812A5007588773 @default.
- W2891156812 hasAuthorship W2891156812A5010046486 @default.
- W2891156812 hasAuthorship W2891156812A5048304251 @default.
- W2891156812 hasAuthorship W2891156812A5049426344 @default.
- W2891156812 hasAuthorship W2891156812A5058900172 @default.
- W2891156812 hasAuthorship W2891156812A5064937199 @default.
- W2891156812 hasConcept C116834253 @default.
- W2891156812 hasConcept C142724271 @default.
- W2891156812 hasConcept C147483822 @default.
- W2891156812 hasConcept C203014093 @default.
- W2891156812 hasConcept C2777484599 @default.
- W2891156812 hasConcept C2778379841 @default.
- W2891156812 hasConcept C2779134260 @default.
- W2891156812 hasConcept C2780174970 @default.
- W2891156812 hasConcept C2908647359 @default.
- W2891156812 hasConcept C59822182 @default.
- W2891156812 hasConcept C71924100 @default.
- W2891156812 hasConcept C86803240 @default.
- W2891156812 hasConcept C99454951 @default.
- W2891156812 hasConceptScore W2891156812C116834253 @default.
- W2891156812 hasConceptScore W2891156812C142724271 @default.
- W2891156812 hasConceptScore W2891156812C147483822 @default.
- W2891156812 hasConceptScore W2891156812C203014093 @default.
- W2891156812 hasConceptScore W2891156812C2777484599 @default.
- W2891156812 hasConceptScore W2891156812C2778379841 @default.
- W2891156812 hasConceptScore W2891156812C2779134260 @default.
- W2891156812 hasConceptScore W2891156812C2780174970 @default.
- W2891156812 hasConceptScore W2891156812C2908647359 @default.
- W2891156812 hasConceptScore W2891156812C59822182 @default.
- W2891156812 hasConceptScore W2891156812C71924100 @default.
- W2891156812 hasConceptScore W2891156812C86803240 @default.
- W2891156812 hasConceptScore W2891156812C99454951 @default.
- W2891156812 hasLocation W28911568121 @default.
- W2891156812 hasOpenAccess W2891156812 @default.
- W2891156812 hasPrimaryLocation W28911568121 @default.
- W2891156812 hasRelatedWork W1532910145 @default.
- W2891156812 hasRelatedWork W1965996152 @default.
- W2891156812 hasRelatedWork W2315877424 @default.
- W2891156812 hasRelatedWork W2330072032 @default.
- W2891156812 hasRelatedWork W2392656817 @default.
- W2891156812 hasRelatedWork W2489843923 @default.
- W2891156812 hasRelatedWork W2605615792 @default.
- W2891156812 hasRelatedWork W2624592255 @default.
- W2891156812 hasRelatedWork W2740588000 @default.
- W2891156812 hasRelatedWork W2742412148 @default.
- W2891156812 hasRelatedWork W2898563269 @default.
- W2891156812 hasRelatedWork W2943936542 @default.
- W2891156812 hasRelatedWork W2970035802 @default.
- W2891156812 hasRelatedWork W3140444269 @default.
- W2891156812 hasRelatedWork W3149431283 @default.
- W2891156812 hasRelatedWork W3150556722 @default.
- W2891156812 hasRelatedWork W3161056143 @default.
- W2891156812 hasRelatedWork W3170806252 @default.
- W2891156812 hasRelatedWork W399009768 @default.
- W2891156812 hasRelatedWork W2182221543 @default.
- W2891156812 isParatext "false" @default.
- W2891156812 isRetracted "false" @default.
- W2891156812 magId "2891156812" @default.
- W2891156812 workType "article" @default.